Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Life sciences-focused search firm Slone Partners has recruited Paul Scagnetti as CEO of biotechnology company ONI. He succeeds founding CEO Bo Jing, who will remain with ONI as a key contributor in product development to help inspire ONI’s next innovations. “Paul Scagnetti is a tremendously experienced, driven, passionate business leader and visionary with both the strategic and tactical
When Adam Slone founded Slone Partners in 2000, he did so with a simple vision – to create a company that stood out from the crowd by delivering high-quality professional customer service in the thriving and often demanding industry of executive search. Through his many network connections, Mr. Slone was attuned to the ways in
Life sciences-focused search firm Slone Partners has expanded with the addition of Bridget K. Burke as chief business officer. This is a new position that reflects the firm’s commitment to long-term business planning and growth. “Bridget Burke is a tremendously talented, driven, and accomplished business leader with a wide range of experience over more than 20 years in
Life sciences-focused search firm Slone Partners has expanded with the addition of Fred McCallum as vice president, client partnerships. “Fred McCallum is a talented and driven leader with a successful track record as an external recruiting business partner with global stakeholders,” said Leslie Loveless, CEO. “He has vast experience with candidate development and recruitment all the way up through
SOUTH RIDING, VA. – February 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Edward Moler, PhD as Vice President of Data Science and Gayathri Swaminath, PhD, MBA as Senior Vice President of Discovery at Juvena Therapeutics, a biotechnology company scaling a computational platform to map the therapeutic potential
SOUTH RIDING, VA. – January 19, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Amy Levin as Vice President of Regulatory Affairs at Mainz Biomed, a biomedical company that develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. In her new role, Levin will be charged with
SOUTH RIDING, VA. – January 13, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul K. Wotton, Ph.D., as Chair of the Board of Directors at Kytopen, an MIT startup biotechnology company leading advancements in novel high-throughput cellular and genome engineering platforms. An experienced CEO, Board
SOUTH RIDING, VA. – December 13, 2022 – There is a talent crunch in the life sciences, particularly in the C-suite, so companies must be innovative in their recruiting approaches. Leslie Loveless, the CEO of Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, shares her perspectives on cutting-edge executive recruiting strategies in a new
New CBO brings more than 25 years of pharmaceutical business development experience SOUTH RIDING, VA. – October 20, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Patrick Genestin as Chief Business Officer at 1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation, and biological automation to
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025